{
  "trial_id": "NCT00216086",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histologically confirmed adenocarcinoma of the rectum < 15 cm from the anal verge",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "without evidence of distant metastasis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Measurable disease",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Either mobile cancers (with clinical stage T3 or T4 by endorectal ultrasound) or fixed cancer (defined as clinical T4 for this study) on palpation",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Malignant disease may not extend to the anal canal (across the dentate line)",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "No prior chemotherapy or radiation therapy to the pelvis",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with clinical stage T 1-2, N0 rectal cancer who are candidates for primary resection are not eligible",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has lower urinary tract symptoms and is otherwise healthy. Recent blood chemistry was normal.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT00216086",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}